Cowen Wins Top Honors At M&A Advisor Awards

Cowen Group, Inc. (NASDAQ:COWN) ("Cowen" or the "Company") today announced that Cowen was recognized at the 15 th Annual M&A Advisor Awards for Corporate and Strategic Deal of the Year (Over $25MM - $50MM). Cowen won this award for its role in the restructuring of Bind Therapeutics, Inc.

Lorie Beers, Managing Director and Head of Cowen's Special Situations Advisory Group, said, "Our balance sheet advisory team is honored to be included among the best in the M&A industry. This award speaks to Cowen's ability to navigate clients through a complex process and deliver an exceptional outcome. This award also reflects the experience and skill we bring to each engagement and the trust that clients place in us. Our team worked closely with our partners in health care investment banking to obtain an outcome that would maximize shareholder value for the client. The Bind Therapeutics transaction began with a comprehensive financial and strategic review process that ultimately concluded in its Section 363 sale to Pfizer."

The M&A Advisor Awards honors and awards companies and professionals whose activities set the standard for M&A transactions. Winners were chosen from over 320 nominees, representing over 615 companies.

About Cowen Group, Inc.

Cowen Group, Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales and trading and prime brokerage services through its two business segments: Ramius and its affiliates make up the Company's alternative investment segment, while Cowen and Company, a member of FINRA and SIPC, and its affiliates make up the Company's broker-dealer segment. Ramius provides alternative asset management solutions to a global client base and manages a significant portion of Cowen's proprietary capital. Cowen and Company and its affiliates offer industry focused investment banking for growth-oriented companies, domain knowledge-driven research, a sales and trading platform for institutional investors and a comprehensive suite of prime brokerage services. Founded in 1918, the firm is headquartered in New York and has offices worldwide. For additional information, visit

View source version on

Copyright Business Wire 2010